Voloridge Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.86M Buy
11,849
+10,770
+998% +$2.6M 0.01% 887
2025
Q1
$263K Buy
+1,079
New +$263K ﹤0.01% 1131
2024
Q4
Sell
-13,185
Closed -$4.41M 1183
2024
Q3
$4.41M Sell
13,185
-20,995
-61% -$7.02M 0.02% 808
2024
Q2
$9.33M Buy
+34,180
New +$9.33M 0.03% 579
2024
Q1
Sell
-9,812
Closed -$3.17M 1152
2023
Q4
$3.17M Buy
+9,812
New +$3.17M 0.01% 719
2023
Q3
Sell
-22,557
Closed -$8.55M 1383
2023
Q2
$8.55M Buy
+22,557
New +$8.55M 0.04% 506
2023
Q1
Sell
-57,093
Closed -$24M 1370
2022
Q4
$24M Buy
57,093
+25,918
+83% +$10.9M 0.13% 219
2022
Q3
$13M Buy
31,175
+26,956
+639% +$11.2M 0.07% 370
2022
Q2
$2.09M Sell
4,219
-18,662
-82% -$9.24M 0.01% 1002
2022
Q1
$12.9M Sell
22,881
-8,275
-27% -$4.66M 0.07% 344
2021
Q4
$23.5M Sell
31,156
-90
-0.3% -$68K 0.13% 212
2021
Q3
$23.3M Buy
31,246
+11,707
+60% +$8.73M 0.15% 168
2021
Q2
$12.6M Buy
19,539
+18,779
+2,471% +$12.1M 0.09% 321
2021
Q1
$434K Sell
760
-15,903
-95% -$9.08M ﹤0.01% 1208
2020
Q4
$9.71M Sell
16,663
-25,008
-60% -$14.6M 0.08% 276
2020
Q3
$21.5M Buy
41,671
+21,799
+110% +$11.2M 0.18% 143
2020
Q2
$8.97M Buy
19,872
+18,319
+1,180% +$8.27M 0.1% 221
2020
Q1
$544K Sell
1,553
-12,674
-89% -$4.44M 0.02% 686
2019
Q4
$5.26M Buy
+14,227
New +$5.26M 0.1% 246
2019
Q2
Sell
-10,065
Closed -$3.08M 767
2019
Q1
$3.08M Buy
10,065
+530
+6% +$162K 0.09% 209
2018
Q4
$2.21M Buy
+9,535
New +$2.21M 0.1% 188
2018
Q3
Sell
-19,040
Closed -$5.49M 304
2018
Q2
$5.49M Sell
19,040
-2,596
-12% -$749K 0.15% 149
2018
Q1
$5.41M Sell
21,636
-10,149
-32% -$2.54M 0.13% 144
2017
Q4
$7.59M Buy
+31,785
New +$7.59M 0.17% 147
2017
Q3
Sell
-23,776
Closed -$5.38M 390
2017
Q2
$5.38M Buy
23,776
+1,226
+5% +$277K 0.13% 168
2017
Q1
$4.5M Buy
22,550
+18,162
+414% +$3.62M 0.11% 216
2016
Q4
$800K Buy
+4,388
New +$800K 0.02% 512